Efficacy of Positive Mental Health Program for Adults - Study Protocol

October 18, 2020 updated by: Carme Ferré Grau

Efficacy of Positive Mental Health Program for Adults

The aim of this study is to evaluate the efficacy of a positive mental health program for adults, designated Mentis Plus+, in community. Our hypotheses are:

  1. compared with the wait-list control group, the persons who join the experimental group and participate in the Mentis Plus+, will have more positive mental health on the end of the program;
  2. in the Mentis Plus+ participants, positive mental health will be increased at the end of the program and at follow-up (three- six months later) and their psychological vulnerability will reduce.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • to be a participant aged ≥ 18;
  • participant without a diagnosis of psychiatric pathology;
  • agree to participate in the program by signing informed consent;
  • participant with the "low-level or languising" in at least one factor of the positive mental health questionnaire

Exclusion Criteria:

  • non-Portuguese speakers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Participants integrate the Mentis Plus+ program
Mentis Plus+ Program was developed based in The Multifactorial Model of Positive Mental Health and its construction resulted from a systematic literature review and validation through focus group. The duration of the Mentis Plus+ program depends on the number of the six factors to be worked on. The Mentis Plus+ lasts at least 7 weeks (1 session per week, lasting 1 hour) and can work individually or in groups (2-12 people). There will be 2 initial sessions of 1 hour each and 3 sessions for each factor to work with duration of 1 hour. Still, a final session and a follow-up session (3-6 months after the program) will be held.
Each factor can be considered a module, so it is a modular program. So, each module has 3 sessions to be carried out in full. It is a systematic program, so the order of the sessions is regulated by the letters A, B and C for each module. The modules to be worked on correspond to the "low-level or languising" factors identified after the application of the positive mental health questionnaire (PMHQ). After the application of the PMHQ, people are grouped with the same module to work.
No Intervention: Participants on a waiting list (Control Group)
Participants in the control group were told they were on a waiting list for 3-6 months, as a minimum, before they integrate the Mentis Plus+ program. Given the preventive nature of this study, a waiting list control group won't bring risks or damages to participants

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive Mental Health Questionnaire (PMHQ) - moment 1
Time Frame: PMHQ will be applied in the baseline of the Mentis Plus+ Program, to both groups
The PMHQ consists of 39 items. In the PMHQ, values between 39 (minimum value) and 156 (maximum value) can be obtained, and higher the value obtained, lower the positive Mental Health level is. Therefore, we can categorize different levels of Positive Mental Health: High level or Flourishing (Results between 39-78), Intermediate level (Results between 79-117) and Low level or Languising (Results between 118-156).
PMHQ will be applied in the baseline of the Mentis Plus+ Program, to both groups
Positive Mental Health Questionnaire (PMHQ) - moment 2
Time Frame: PMHQ will be applied up to 18 weeks of the Mentis Plus + Program,to both groups
The PMHQ consists of 39 items. In the PMHQ, values between 39 (minimum value) and 156 (maximum value) can be obtained, and higher the value obtained, lower the positive Mental Health level is. Therefore, we can categorize different levels of Positive Mental Health: High level or Flourishing (Results between 39-78), Intermediate level (Results between 79-117) and Low level or Languising (Results between 118-156).
PMHQ will be applied up to 18 weeks of the Mentis Plus + Program,to both groups
Positive Mental Health Questionnaire (PMHQ) - moment 3
Time Frame: The PMHQ will be reapplied for follow-up of the evaluation, after completion of the study, on average 3 months, in both groups
The PMHQ consists of 39 items. In the PMHQ, values between 39 (minimum value) and 156 (maximum value) can be obtained, and higher the value obtained, lower the positive Mental Health level is. Therefore, we can categorize different levels of Positive Mental Health: High level or Flourishing (Results between 39-78), Intermediate level (Results between 79-117) and Low level or Languising (Results between 118-156).
The PMHQ will be reapplied for follow-up of the evaluation, after completion of the study, on average 3 months, in both groups
Psychological Vulnerability Scale (PVS) - moment 1
Time Frame: PVS will be applied in the baseline of the Mentis Plus+ Program, to both groups

The PVS is a six-item scale. Each item is measured in a scale Frequency Likert five points (1-5), where a higher number corresponds to greater frequency (does not describe me at all = 1 to describes me very well = 5). Possible total scores range from 6 to 30, with higher scores indicating greater psychological vulnerability.

greater psychological vulnerability.

PVS will be applied in the baseline of the Mentis Plus+ Program, to both groups
Psychological Vulnerability Scale (PVS) - moment 2
Time Frame: PVS will be applied up to 18 weeks of the Mentis Plus + Program,to both groups

The PVS is a six-item scale. Each item is measured in a scale Frequency Likert five points (1-5), where a higher number corresponds to greater frequency (does not describe me at all = 1 to describes me very well = 5). Possible total scores range from 6 to 30, with higher scores indicating greater psychological vulnerability.

greater psychological vulnerability.

PVS will be applied up to 18 weeks of the Mentis Plus + Program,to both groups
Psychological Vulnerability Scale (PVS) - moment 3
Time Frame: PVS will be reapplied for follow-up of the evaluation, after completion of the study, on average 3 months, in both groups

The PVS is a six-item scale. Each item is measured in a scale Frequency Likert five points (1-5), where a higher number corresponds to greater frequency (does not describe me at all = 1 to describes me very well = 5). Possible total scores range from 6 to 30, with higher scores indicating greater psychological vulnerability.

greater psychological vulnerability.

PVS will be reapplied for follow-up of the evaluation, after completion of the study, on average 3 months, in both groups

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sociodemografic and clinical data - moment 1
Time Frame: Sociodemografic and clinical data will be applied in the baseline of the Mentis Plus+ Program, to both groups
Gender, age, marital status, educational level, professional bond, displacement of usual residence, years of professional practice, hours of work per week, history of mental illness, health behaviors in the last month, consumption of psychoactive substances
Sociodemografic and clinical data will be applied in the baseline of the Mentis Plus+ Program, to both groups
Sociodemografic and clinical data - moment 2
Time Frame: Sociodemografic and clinical data will be applied up to 18 weeks of the Mentis Plus + Program,to both groups
Gender, age, marital status, educational level, professional bond, displacement of usual residence, years of professional practice, hours of work per week, history of mental illness, health behaviors in the last month, consumption of psychoactive substances
Sociodemografic and clinical data will be applied up to 18 weeks of the Mentis Plus + Program,to both groups
Sociodemografic and clinical data - moment 3
Time Frame: Sociodemografic and clinical data will be reapplied for follow-up of the evaluation, after completion of the study, on average 3 months, in both groups
Gender, age, marital status, educational level, professional bond, displacement of usual residence, years of professional practice, hours of work per week, history of mental illness, health behaviors in the last month, consumption of psychoactive substances
Sociodemografic and clinical data will be reapplied for follow-up of the evaluation, after completion of the study, on average 3 months, in both groups

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2020

Primary Completion (Anticipated)

August 31, 2021

Study Completion (Anticipated)

December 31, 2021

Study Registration Dates

First Submitted

May 15, 2020

First Submitted That Met QC Criteria

October 18, 2020

First Posted (Actual)

October 23, 2020

Study Record Updates

Last Update Posted (Actual)

October 23, 2020

Last Update Submitted That Met QC Criteria

October 18, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2020PMHP.PT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

Clinical Trials on Mentis Plus+ (Experimental Group)

3
Subscribe